TEVA

#330
Teva Pharmaceutical Industries Limited American Depositary Shar
35.3 3 USD
+2.29%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
34.64
35.45
년간 변동
0.34
37.34
일일 변동
+2.29%
월간 변동
-1.67%
6달 변화
+32.87%
년간 변동율
+84.93%
이전 종가
34.5 4
Open
34.6 5
저가
34.6 4
High
35.4 5
양
5 074
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 41.14 B
  • Employee 33 K
  • Founded N/A
  • CEO Richard Francis
  • Website www.tevapharm.com
  • Headquarter Israel
  • FIGI BBG000C0CD58
  • Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
25.79
주가매출액비율
2.1

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

뉴스